Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
NCT ID: NCT04918082
Last Updated: 2024-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
133 participants
OBSERVATIONAL
2020-10-28
2026-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breast Cancer and Quality of Life
NCT01661816
5 Years Follow-up With Adjuvant Therapy for Women With Breast Invasive Carcinoma
NCT02791750
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
NCT01282931
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
NCT05926024
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes
NCT03333122
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quality of life questionnaires
Patients' quality of life will be assessed with self-reported items through both the EORTC-QLQ-C30 and EORTC-QLQ-BR23 modules.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have read the information note and have indicated that they do not wish to participate in the study
* Patient with social security coverage.
Exclusion Criteria
* Patient with insitu breast cancer
* Patient with a second cancer
* Patient with cancer within 5 years prior to inclusion
* Patient who could not answer quality of life questionnaires
* Patient not fluent in French
* Person under legal protection (safeguard of justice, guardianship, curators , etc.).
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Center of Martinique
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clarisse JOACHIM-CONTARET
Role: PRINCIPAL_INVESTIGATOR
CHU Martinique
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Martinique
Fort-de-France, , Martinique
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A01290-39
Identifier Type: OTHER
Identifier Source: secondary_id
20_RIPH3_06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.